Meet our
leadership team

Medisca’s leaders are passionate innovators and forward-thinkers, dedicated to driving our company's success and improving healthcare for all. 

ph-banner.jpg

Message from
the founders

When I founded Medisca, my dream was to create a company that not only offered exceptional products and services but also made a positive impact on the healthcare industry. I am proud to say that, with the unwavering support of our dedicated team, passionate customers and valued partners, we have achieved this and more.

Our commitment to innovation, quality and patient care has been the driving force behind our success, and with over 30 years of experience, we continue to push the boundaries of what's possible, innovating and leading the way in compounding.

As we look to the future, I am excited about the possibilities and the impact we can make together. Medisca remains dedicated to driving innovation, setting the industry standard and providing healthcare professionals with the tools they need to better serve their patients. 

Thank you for being a part of the Medisca family and for your support as we continue to lead the way.


Tony Dos Santos & Maria Zaccardo
Founder & President, Executive Vice President

Rectangle 19
Rectangle 20 (1)

Leadership team

Tony Dos Santos

Founder & President

Maria Zaccardo

Executive Vice President

Mitchell Rubin

Chief Financial Officer

Panagiota Danopoulos

Senior Vice President of Global Strategy and Innovation

Peng Li

Vice President of Strategic Partnerships and Operations

Andrew Harb

General Manager of Australia and Emerging Markets

Caroline Cohen

Director of People and Culture

Dea Bastos

Director of Sales Strategy and Planning

James Warren

Director of Information Technology

Maurizio De Stefano

Vice President of Compliance and Education

Milton Almeida

Senior Director of Sales North America

Sandor Szentannai

Director of Supply Chain, Demand, and Planning

Vanessa Pinheiro

Bs Pharm, MSc, RPh
Vanessa Pinheiro

Partner with us

Discover the benefits of partnering with a global leader in pharmaceutical compounding.